NuCana plc (NASDAQ:NCNA), (“NuCana” or the “Company”), announced that it has received a written notification (the “Notification Letter”) from the Listing Qualifications Department of
NuCana plc (NASDAQ:NCNA) announced that it received written notification (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq") dated January 3, 2023, indicating that, based upon a
Gainers
Cyclerion Therapeutics (NASDAQ:CYCN) shares increased by 10.8% to $0.39 during Monday's after-market session. The market value of their outstanding shares is at $16.8 million.